Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

XSSC:600613 Stock Report

Market Cap: CN¥3.5b

Shanghai Shenqi Pharmaceutical Investment Management Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Feng Bin

Chief executive officer

CN¥480.3k

Total compensation

CEO salary percentagen/a
CEO tenure13.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Feng Bin (52 yo)

13.4yrs

Tenure

CN¥480,300

Compensation

Mr. Feng Bin is a Director of Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. (formerly known as Shanghai Wingsung Investment Management Co., Ltd.) and serves as its General Manager since Jun...